AS Latvijas Juras medicinas centrs

    AS Latvijas Juras medicinas centrs

    MMUN:UOM
    - -
    EUR
    - -
    - -
    29.54P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    6.35
    6.84
    7.23
    7.75
    7.35
    8.34
    9.09
    8.8
    11.7
    12.13
    12.31
    12.74
    - -
    12.86
    Basic EPS, GAAP
    -0.4
    1.52
    -0.47
    0.14
    0.63
    -0.1
    0.21
    0.34
    1.1
    0.78
    -0.78
    0.23
    - -
    0.3
    Free Cash Flow per Basic Share
    0.12
    0.27
    0.13
    -0.7
    -0.16
    0.64
    0.28
    0.27
    -0.86
    0.58
    -0.71
    0.21
    - -
    -0.26
    Dividend per Share
    - -
    - -
    - -
    0.03
    0.4
    0.4
    0.1
    0.55
    0.07
    0.2
    0.1
    - -
    - -
    - -
    Book Value per Share
    3.72
    5.19
    4.73
    4.99
    4.33
    3.83
    3.93
    3.7
    4.75
    5.34
    4.46
    4.41
    - -
    4.61
    Tangible Book Value per Share
    4.74
    9.66
    8.89
    8.68
    7.27
    6.77
    6.88
    6.86
    7.93
    8.51
    7.75
    7.71
    - -
    7.91
    Basic Weighted Avg Shares
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    - -
    1
    Sales/Revenue/Turnover
    5
    5
    6
    6
    6
    7
    7
    7
    9
    10
    10
    10
    10
    10
    Operating Margin (%)
    -6.41
    18.77
    -3.51
    -0.27
    0.45
    -3.26
    0.66
    2.1
    8.19
    5.23
    -1.81
    0.71
    1.1
    1.1
    Depreciation Expense
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    - -
    Net Income, GAAP
    - -
    1
    - -
    - -
    1
    - -
    - -
    - -
    1
    1
    -1
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    3.06
    - -
    0.57
    0.39
    0.07
    0.1
    - -
    0.33
    6.69
    6.69
    Profit Margin (%)
    -6.28
    22.22
    -6.48
    1.81
    8.62
    -1.2
    2.26
    3.86
    9.4
    6.45
    -6.34
    1.82
    2.34
    2.34
    Working Capital
    1
    1
    1
    2
    1
    2
    2
    1
    1
    1
    -1
    -1
    - -
    - -
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    4
    8
    7
    7
    6
    5
    6
    6
    6
    7
    6
    6
    6
    6
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    12.54
    - -
    5.29
    8.93
    25.95
    15.5
    - -
    5.22
    6.68
    6.68
    Return on Common Equity (%)
    -10.46
    34.17
    -9.45
    2.84
    13.77
    -2.45
    5.29
    8.93
    25.95
    15.5
    -15.94
    5.22
    6.68
    6.68

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1
    1
    1
    Market Capitalization
    5
    5
    7

    Working Capital

    EUR

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    2
    2
    2
    Cash, Cash Equivalents & STI
    1
    1
    1
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    2
    2
    2
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -0.86%
    3.09%
    2.61%
    Free Cash Flow
    -243.29%
    -232.03%
    -223.25%
    Net Income, GAAP
    -22.61%
    -21.28%
    30.15%
    Sales/Revenue/Turnover
    6.33%
    8.36%
    0.97%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    2
    2
    3
    3
    10
    2024
    3
    2
    3
    3
    10
    2025
    3
    3
    3
    3
    10

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.17
    - -
    - -
    - -
    -0.78
    2024
    0.11
    - -
    - -
    - -
    0.23
    2025
    0.04
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    0.1
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business